Could a lab test on your own tumor cells beat glioblastoma?

NCT ID NCT06512311

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a personalized approach to choosing cancer drugs can help people with glioblastoma, an aggressive brain tumor. Researchers will take tumor tissue from each patient, grow the cells in a lab, and test many drugs to find which ones work best. Then, patients will receive a treatment plan based on those results. The trial will compare survival and quality of life between 240 patients who get this personalized screening and those who receive standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Personalized drug screening using patient-derived cells
What this could lead to
If successful, this could show that tailoring cancer drugs to an individual's tumor cells improves survival for glioblastoma patients.
What could go wrong
This is an early-stage trial without a defined phase, and the approach is complex. It may not work for all patients or may not improve outcomes compared to standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AKH Vienna, Department for Internal Medicine I, Oncology

    RECRUITING

    Vienna, State of Vienna, 1090, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.